Encision, Inc. (ECIA)
| Market Cap | 6.37M |
| Revenue (ttm) | 7.05M |
| Net Income (ttm) | -176,823 |
| Shares Out | 11.58M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 22 |
| Last Price | $0.5500 |
| Previous Close | $0.6000 |
| Change ($) | -0.0500 |
| Change (%) | -8.33% |
| Day's Open | 0.5500 |
| Day's Range | 0.5000 - 0.6000 |
| Day's Volume | 16,130 |
| 52-Week Range | 0.35 - 0.75 |
News
There are no news available yet.
About ECIA
Encision, a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which... [Read more...]
| Industry Medical Instruments & Supplies | IPO Date Jun 25, 1996 |
| CEO Gregory J. Trudel | Employees 30 |
| Stock Exchange OTCMKTS | Ticker Symbol ECIA |
Financial Performance
In 2019, Encision's revenue was $7.67 million, a decrease of -12.86% compared to the previous year's $8.80 million. Losses were -$198,312, -16.00% less than in 2018.